575
Participants
Start Date
March 31, 2012
Primary Completion Date
December 31, 2015
Study Completion Date
January 31, 2016
Quadrivalent HPV Vaccine
Participants were prescribed one intramuscular (IM) injection of the quadrivalent HPV vaccine in the upper arm or thigh at baseline and Weeks 8 and 24.
Placebo Vaccine for Male Participants Only
Participants were prescribed one IM injection of the placebo vaccine in the upper arm or thigh at baseline and Weeks 8 and 24.
Placebo Vaccine for Female Participants Only
Participants were prescribed one IM injection of the placebo vaccine in the upper arm or thigh at baseline and Weeks 8 and 24.
Weill Cornell Chelsea CRS, New York
NY Univ. HIV/AIDS CRS, New York
University of Rochester Adult HIV Therapeutic Strategies Network CRS, Rochester
University of Pittsburgh CRS, Pittsburgh
Chapel Hill CRS, Chapel Hill
Cincinnati Clinical Research Site, Cincinnati
Northwestern University CRS, Chicago
Rush University CRS, Chicago
Houston AIDS Research Team CRS, Houston
University of Colorado Hospital CRS, Aurora
Denver Public Health CRS, Denver
UCLA CARE Center CRS, Los Angeles
UCSD Antiviral Research Center CRS, San Diego
Ucsf Hiv/Aids Crs, San Francisco
Stanford AIDS Clinical Trials Unit CRS, Palo Alto
Massachusetts General Hospital CRS (MGH CRS), Boston
Boston Medical Center CRS, Boston
Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston
Washington University Therapeutics (WT) CRS, St Louis
New Jersey Medical School Clinical Research Center CRS, Newark
Columbia P&S CRS, New York
The Miriam Hospital Clinical Research Site (TMH CRS) CRS, Providence
Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio de Janeiro
Puerto Rico AIDS Clinical Trials Unit CRS, San Juan
National Institute of Allergy and Infectious Diseases (NIAID)
NIH